Rxivist logo

Immunogenic potential of neopeptides depends on parent protein subcellular location

By Andrea Castro, Sahar Kaabinejadian, William Hildebrand, Maurizio Zanetti, Hannah Carter

Posted 16 Oct 2021
bioRxiv DOI: 10.1101/2021.10.16.464599

Antigen presentation via the major histocompatibility complex (MHC) is essential for anti-tumor immunity, however the rules that determine what tumor-derived peptides will be immunogenic are still incompletely understood. Here we investigate whether protein subcellular location driven constraints on accessibility of peptides to the MHC associate with potential for peptide immunogenicity. Analyzing over 380,000 of peptides from studies of MHC presentation and peptide immunogenicity, we find clear spatial biases in both eluted and immunogenic peptides. We find that including parent protein location improves prediction of peptide immunogenicity in multiple datasets. In human immunotherapy cohorts, location was associated with response to a neoantigen vaccine, and immune checkpoint blockade responders generally had a higher burden of neopeptides from accessible locations. We conclude that protein subcellular location adds important information for optimizing immunotherapies.

Download data

  • Downloaded 167 times
  • Download rankings, all-time:
    • Site-wide: 154,888
    • In bioinformatics: 11,783
  • Year to date:
    • Site-wide: 6,944
  • Since beginning of last month:
    • Site-wide: 28,552

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide